Laith Al Momani, MD
Gastroenterology · Kansas City, MONPI 1740642065
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $206,168 of the $248,917 with a category attached, or 82.8%. 6 manufacturers reported payments, led by AbbVie at 32.5% of the total. 2025 is the largest year on record at $157,177, more than ten times the $33 reported in 2022. Among gastroenterology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $1190.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$81K
- Takeda Pharmaceuticals U.S.A., Inc.$80K
- Lilly USA, LLC$57K
- Johnson & Johnson$23K
- Eli Lilly$7K
- Pentax Of America, Inc.$368
Across 2 payments — averaging $13,650 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$27K
What the payments were for
- Consulting fees$7,1503%
- Speaking & faculty fees$206,16883%
- Travel & lodging$31,35313%
- Food & beverage$3,8282%
- Education$510%
- Other$3680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $80,902 |
| Takeda Pharmaceuticals U.S.A., Inc. | 58 | $80,459 |
| Lilly USA, LLC | 59 | $57,157 |
| Johnson & Johnson | 19 | $22,680 |
| Eli Lilly | 5 | $7,351 |
| Pentax Of America, Inc. | 1 | $368 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$248,917 in reported general payments places this provider in the 95th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 34 | $911,507 |
| LialdaMesalamine | 11 | $7,841 |
| Budesonide DrBudesonide | 12 | $6,032 |
| Esomeprazole Magnesium | 98 | $4,220 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 240 | $3,540 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 31 | $1,917 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 97 | $1,740 |
| Omeprazole | 43 | $473 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 16 | $362 |
| Pantoprazole Sodium | 15 | $261 |
| Famotidine | 15 | $175 |
| Prednisone | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $22,680 | $911,50734 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 374 gastroenterology providers in Missouri.
Other gastroenterology in Kansas City
- Ahmed SaeedKansas City$246K
- Tahar MahmoudiKansas City$114K
- Hillary BownikKansas City$85K
- Amit RastogiKansas City$63K
- Rajiv ChhabraKansas City$29K
- Bradley FreilichKansas City$26K
- Prashant PandyaKansas City$21K
- Syed JafriKansas City$20K
- Gregory MerrittKansas City$16K
- Gregory SayukSaint Louis$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.